ACRS - Aclaris Therapeutics, Inc.

QQQ $ 439.55 $ -0.26 (-0.06 %)

DIA $ 390.50 $ 1.74 (0.45 %)

SPY $ 517.10 $ 0.05 (0.01 %)

TLT $ 90.18 $ -0.55 (-0.61 %)

GLD $ 213.58 $ -0.63 (-0.29 %)

Previous Close

$ 1.22

Open

$ 1.28

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 1.21 - $ 1.34

52 Week Range

$ 0.59 - $ 11.12

Volume

1,231,832

Average Volume

Market Cap

86.71M

Beta (5Y Monthly)

$ 1.44

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-07-2024	03-31-2024	10-Q
2	02-27-2024	12-31-2023	10-K
3	11-06-2023	09-30-2023	10-Q
4	08-07-2023	06-30-2023	10-Q
5	05-08-2023	03-31-2023	10-Q
6	02-23-2023	12-31-2022	10-K
7	11-08-2022	09-30-2022	10-Q
8	08-03-2022	06-30-2022	10-Q
9	05-10-2022	03-31-2022	10-Q
10	02-24-2022	12-31-2021	10-K
11	11-02-2021	09-30-2021	10-Q
12	08-05-2021	06-30-2021	10-Q
13	05-07-2021	03-31-2021	10-Q
14	02-25-2021	12-31-2020	10-K
15	11-04-2020	09-30-2020	10-Q
16	08-07-2020	06-30-2020	10-Q
17	05-07-2020	03-31-2020	10-Q
18	02-25-2020	12-31-2019	10-K
19	11-07-2019	09-30-2019	10-Q
20	08-08-2019	06-30-2019	10-Q
21	05-08-2019	03-31-2019	10-Q
22	03-18-2019	12-31-2018	10-K
23	11-06-2018	09-30-2018	10-Q
24	08-03-2018	06-30-2018	10-Q
25	05-08-2018	03-31-2018	10-Q
26	03-12-2018	12-31-2017	10-K
27	11-07-2017	09-30-2017	10-Q
28	08-08-2017	06-30-2017	10-Q
29	05-09-2017	03-31-2017	10-Q
30	03-15-2017	12-31-2016	10-K
31	11-03-2016	09-30-2016	10-Q
32	08-11-2016	06-30-2016	10-Q
33	05-11-2016	03-31-2016	10-Q
34	03-23-2016	12-31-2015	10-K
35	11-18-2015	09-30-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Aclaris Therapeutics Q1 EPS $(0.24) Beats ...
05/07/2024 20:02:47

Aclaris Therapeutics (NASDAQ:ACRS) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of ...

lumen-technologies-and-2-other-stocks-under-2-insiders-are-buying

Lumen Technologies And 2 Other Stocks Unde...
03/06/2024 11:56:50

The Dow Jones index closed lower by over 400 points on Tuesday. When insiders purchase or sell shares, it indicates their confi...

Aclaris Therapeutics: Q4 Earnings Insights
02/27/2024 13:55:06

aclaris-therapeutics-ati-1777-faces-uphill-battle-in-atopic-dermatitis-treatment-landscape-analyst-downgrades

Aclaris Therapeutics' ATI-1777 Faces Uphil...
01/22/2024 19:37:34

HC Wainwright downgrades Aclaris Therapeutics post Phase 2b results of ATI-1777 for atopic dermatitis. Analyzing efficacy, comm...

why-commscope-shares-are-trading-lower-by-around-7-here-are-other-stocks-moving-in-mondays-mid-day-session

Why CommScope Shares Are Trading Lower By ...
01/22/2024 18:08:22

Shares of CommScope Holding Company, Inc. (NASDAQ: COMM) fell sharply during Monday’s session. B of A Securities analyst Tal L...

why-coherus-biosciences-shares-are-trading-higher-by-22-here-are-20-stocks-moving-premarket

Why Coherus BioSciences Shares Are Trading...
01/22/2024 13:21:24

Shares of Coherus BioSciences, Inc. (NASDAQ: CHRS) shares rose sharply in today’s pre-market trading after the company announc...

HC Wainwright & Co. Downgrades Aclaris The...
01/22/2024 12:14:49

HC Wainwright & Co. analyst Raghuram Selvaraju downgrades Aclaris Therapeutics (NASDAQ:ACRS) from Buy to Neutral.

12-health-care-stocks-moving-in-tuesdays-intraday-session

12 Health Care Stocks Moving In Tuesday's ...
01/16/2024 17:31:05

why-is-dermatology-focused-aclaris-therapeutics-stock-trading-higher-today

Why Is Dermatology Focused Aclaris Therape...
01/16/2024 16:47:48

Aclaris Therapeutics leadership changes and strategic review. Preliminary unaudited data as of Dec 31, 2023, reveals approximat...

Aclaris Therapeutics Announced That Dougla...
01/16/2024 12:10:07

The Analyst Landscape: 4 Takes On Aclaris ...
01/11/2024 19:00:17

BTIG Downgrades Aclaris Therapeutics to Ne...
01/11/2024 13:11:31

BTIG analyst Julian Harrison downgrades Aclaris Therapeutics (NASDAQ:ACRS) from Buy to Neutral.

analyst-highlights-aclaris-therapeutics-encouraging-efficacy-for-eczema-candidate-but-cautions-on-data-variations

Analyst Highlights Aclaris Therapeutics' E...
01/10/2024 20:12:51

Wednesday, Aclaris Therapeutics Inc (NASDAQ: ACRS) released topline results from its Phase 2b study of ATI-1777, an investigati...

Crude Oil Falls 1%; Amarin Shares Spike Hi...
01/10/2024 19:16:25

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining over 100 points on Wednesday. The Dow tr...

why-wd-40-shares-are-trading-higher-by-over-17-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Why WD-40 Shares Are Trading Higher By Ove...
01/10/2024 18:06:18

Shares of WD-40 Company (NASDAQ: WDFC) rose sharply during Wednesday’s session after the company reported better-than-expected ...

12-health-care-stocks-moving-in-wednesdays-intraday-session

12 Health Care Stocks Moving In Wednesday'...
01/10/2024 17:31:03

Nasdaq Gains 50 Points; US Crude Inventori...
01/10/2024 17:04:00

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 50 points on Wednesday. The Dow tra...

aclaris-therapeutics-shares-fall-on-mixed-results-from-mid-stage-eczema-trial

Aclaris Therapeutics Shares Fall On Mixed ...
01/10/2024 16:39:05

Aclaris Therapeutics Inc (NASDAQ: ACRS) released topline results from its Phase 2b study of ATI-1777, an investigational topica...

dow-surges-100-points-pricesmart-earnings-top-views

Dow Surges 100 Points; PriceSmart Earnings...
01/10/2024 14:50:56

U.S. stocks traded higher this morning, with the Dow Jones index gaining over 100 points on Wednesday. Following the market op...

12-health-care-stocks-moving-in-wednesdays-pre-market-session

12 Health Care Stocks Moving In Wednesday'...
01/10/2024 13:05:53